VeriSign, Inc. (VRSN) Reports Results for Q2 2025; Baird Raises PT to $340
[caption id="attachment_1235243" align="aligncenter" width="1456"] A medical professional demonstrating the use of a Software-Based Prescription Digital Therapeutics Platform for treating Type 2 Diabetes...